AIRWAY MANAGEMENT INC.

Airway Management Inc. manufactures and distributes TAP (Thornton Adjustable Positioner) Sleep Care devices, a portfolio of FDA-cleared oral appliances and hybrid therapies designed to treat obstructive sleep apnea (OSA) and snoring. The company's product line includes myTAP (chairside-fitted mandibular advancement device), customTAP (lab-fabricated personalized oral appliance), myTAP PAP (hybrid device combining oral tray with CPAP mask), customTAP PAP (combination therapy for complex cases), and the newly FDA-cleared Nylon flexTAP—the first digitally printed single-point midline oral appliance. TAP devices serve as effective CPAP alternatives for patients with sleep-related breathing disorders, particularly those intolerant to traditional CPAP therapy. The company distributes through a network of dentists, physicians, and authorized distributors. Products are FDA 510(k)-cleared and meet regulatory standards for oral sleep appliance therapy. Clinical evidence demonstrates efficacy in improving sleep quality and breathing in moderate-to-severe OSA patients, with 72% of CPAP-intolerant patients achieving major improvement according to institutional outcomes studies. The company supports multiple customer segments including patients, dental professionals, medical providers, and distributors with educational resources, fitting guidance, and provider location services.